Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
By tracking when symptoms occur, how long they last, and whether they recur, you can create a detailed map of your body's responses
FDA Approval Timelines and Accessibility Semaglutide (Wegovy) was approved for weight loss in 2021, whereas tirzepatide has only been approved for type 2 diabetes approval for weight loss is currently pending
Tirzepatide also produces significant insulin sensitivity improvements, outperforming semaglutide in head-to-head diabetes trials
The cottage cheese alone delivers 14 grams of protein, and combined with the bread, you reach 26 grams in a meal so small it barely registers as eating
Key Takeaways Yes retatrutide causes some muscle (lean mass) loss, but it is not selectively "eating" your muscle